These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27070052)

  • 1. Safety concerns with long-term opioid use.
    Harned M; Sloan P
    Expert Opin Drug Saf; 2016 Jul; 15(7):955-62. PubMed ID: 27070052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy.
    Miller M; Barber CW; Leatherman S; Fonda J; Hermos JA; Cho K; Gagnon DR
    JAMA Intern Med; 2015 Apr; 175(4):608-15. PubMed ID: 25686208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in opioid prescription for chronic non-cancer pain.
    Snidvongs S; Mehta V
    Postgrad Med J; 2012 Feb; 88(1036):66-72. PubMed ID: 21725034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.
    Rauck RL
    Pain Pract; 2019 Apr; 19(4):443-454. PubMed ID: 30597739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patients.
    Coplan PM; Cepeda MS; Petronis KR; DeVeaugh-Geiss A; Barsdorf AI; Kern DM; Fanelli R
    Postgrad Med; 2020 Jan; 132(1):44-51. PubMed ID: 31721609
    [No Abstract]   [Full Text] [Related]  

  • 9. Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality.
    Dasgupta N; Funk MJ; Proescholdbell S; Hirsch A; Ribisl KM; Marshall S
    Pain Med; 2016 Jan; 17(1):85-98. PubMed ID: 26333030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsible prescribing of opioids for the management of chronic pain.
    Nicholson B
    Drugs; 2003; 63(1):17-32. PubMed ID: 12487620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.
    Cheatle MD
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):751-4. PubMed ID: 26933873
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
    Stanos S
    Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.
    Davis MP
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):823-31. PubMed ID: 27253690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential.
    Hale ME; Ma Y; Malamut R
    J Opioid Manag; 2016; 12(2):139-47. PubMed ID: 27194199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of prescription opioid abuse in the United States: focus on route of administration.
    Kirsh K; Peppin J; Coleman J
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):348-61. PubMed ID: 23675595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Opioid-Use Disorder and Overdose.
    Webster LR
    Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?
    Raffa RB; Taylor R; Pergolizzi JV
    Expert Opin Drug Saf; 2014 Feb; 13(2):181-90. PubMed ID: 24206269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
    Gudin J
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.
    Nicholson B
    Postgrad Med; 2013 Jan; 125(1):115-27. PubMed ID: 23391677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of extended-release opioid analgesics for the treatment of chronic pain.
    Gudin JA
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):49-61. PubMed ID: 23527669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.